Transfusion – Antenatal Serology —
Training activity: 4

Details

Identify clinically significant antibodies and determine antibody concentration by:

• Titration
• Quantification

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

• Clinical impact
• Antibody titration and titration scores
• Antibody quantification
• Antenatal testing protocol in relation to guidelines and laboratory procedures

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

• What do you already know about clinically significant antibodies in the context of antenatal serology?
• What is your current understanding of titration and quantification methods for antibody concentration?
• What specific guidelines or laboratory policies related to identifying clinically significant antibodies and performing titrations/quantifications should you review?
• How will you prepare to perform these techniques accurately? Will you discuss the process with your training officer to ensure clarity?
• What specific insights do you hope to gain regarding the interpretation of titration and quantification results and their clinical significance?
• What challenges do you anticipate in identifying clinically significant antibodies or performing these techniques, and how might you address them?
• How do you feel about undertaking this activity?

In action

• Pay attention to your actions as you identify potentially clinically significant antibodies. How are you approaching the identification process? Why are you following specific steps or guidelines?
• What decisions are you making as you perform the titration and quantification techniques? For example, how are you determining the end point of a titration or ensuring the accuracy of your quantification method?
• How effective are your actions in identifying the clinically significant antibodies and determining their concentration? Are you encountering any difficulties or unexpected results?
• What challenges are you facing during the titration or quantification process? Are there any technical issues or uncertainties in your interpretation?
• How does this activity connect to your existing knowledge and skills in antenatal serology? Does it reinforce or challenge your understanding?
• Are there alternative approaches you could be considering if you encounter difficulties in identifying an antibody’s significance or performing the techniques?
• What support or guidance might you need in the moment if you are unsure about a step or the interpretation of a result? Who would you ask for help (e.g., a senior colleague)?
• Are you working within the established laboratory policies and guidelines for this activity?

On action

• What were the key steps you took during the process of identifying potentially clinically significant antibodies?
  • What did you observe during the titration and quantification procedures?
  • Were there any unexpected observations or technical challenges?
  • What specific results did you obtain for antibody concentration?
  • Did you notice any discrepancies between expected outcomes or established knowledge and your findings?
  • How did your reflect-in-action (your thoughts and adjustments during the activity) influence how you performed the identification and quantification?
• What new skills or knowledge did you develop or improve related to antibody identification and quantification techniques through this activity?
  • Were there any unexpected challenges or successes during the activity?
  • What did you learn from these specific instances?
  • Did you gain a better understanding of the clinical significance of different antibody concentrations?
  • In what ways did your reflection-in-action (during the activity) influence your understanding of the results or the process itself?
  • How does this experience relate to the requirements for post-programme practice in identifying and quantifying clinically significant antibodies?
• What areas for continued development have been identified as a result of this activity in relation to antibody identification and quantification?
  • How can you apply the learning from this activity to your routine practice in the laboratory?
  • What specific actions / ‘next steps’ will you now take to support the assimilation of what you have learned, such as reviewing specific protocols or seeking further guidance?
  • What support or resources might you need to further develop your skills in this area?

Beyond action

• Have you had opportunities since completing this training activity to evaluate and re-evaluate your experiences in identifying clinically significant antibodies and determining their concentration through titration and quantification?
• Have you revisited your initial reflections (reflect-on-action) on this training activity? In light of your further training and experiences, what new learning or insights can you now identify?
• Recognising that this training activity is part of your overall training, how has the experience of performing titration and quantification supported the development of skills that you now use in other aspects of your work, such as interpreting complex results or troubleshooting assays?
• How have you applied the knowledge and skills gained from this training activity in your routine work within the laboratory since the original experience? How has your subsequent practice in antenatal serology or related areas been influenced by this activity?
• What transferable skills, such as meticulous technique, attention to detail, and analytical interpretation, did you develop or strengthen through this training activity that will be valuable in your future professional practice?
• Identify clear actions for continued development of your skills in identifying and quantifying clinically significant antibodies. How will you stay updated with best practices and technological advancements in this area as your career progresses?

Relevant learning outcomes

#	Outcome
# 1	Outcome Practice in accordance with antenatal serology standards and guidelines.
# 2	Outcome Perform acceptance testing of samples requiring antenatal investigation.
# 3	Outcome Perform and interpret clinical and laboratory investigations to identify cases of haemolytic disease of the fetus or newborn (HDFN).
# 4	Outcome Identify sequential testing algorithms appropriate to the samples under investigation for HDFN.
# 5	Outcome Predict current and future pregnancies at highest risk of HDFN.
# 6	Outcome Identify and advise healthcare professionals on appropriate actions to manage HDFN.
# 7	Outcome Develop management plans including selection of blood components for mother, fetus and neonates during pregnancy.